Breast Cancer: 1,219 Real Stories

1,219 stories match breast cancer. 974 of them mention surgery.

Chickie, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I Invasive Lobular Carcinoma: Chickie's Patient Story

Patient Info: Chickie, Female, 70+ | Stage I

Biomarkers: Oncotype DX scores 16 and 17

Chickie had bilateral Stage I ILC treated with bilateral lumpectomy, clear margins, negative lymph nodes, low Oncotype DX scores that avoided chemotherapy, and photon radiation.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Kathy, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I Invasive Lobular Carcinoma: Kathy's Patient Story

Patient Info: Kathy, Female | Stage I

Kathy was diagnosed with Stage IB invasive lobular carcinoma in 2019 after MRI and second opinion revealed a right-breast abnormality missed by mammography, and she later joined LBCA advocacy and research efforts.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Beth, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV Invasive Lobular Carcinoma: Beth's Patient Story

Patient Info: Beth, Female, 60s | Stage IV

Metastatic Site: Bone

Beth first received chemotherapy and hormone therapy for Stage II pleomorphic ILC in 2005, then developed bone metastases 16 years later and continued living actively with metastatic disease, including a later progression.

Lobular Breast Cancer Alliance
OutcomeLiving With Cancer
Lucy, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Lucy's Survivor Story

Patient Info: Lucy, Female, 40s | Stage III

Lucy was treated for Stage III invasive lobular carcinoma with double mastectomy, aggressive chemotherapy, and radiation, and later celebrated 20 years with no evidence of disease.

Lobular Breast Cancer Alliance
OutcomeCancer-Free / NED
Alma, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Alma's Patient Story

Patient Info: Alma, Female | Stage II

Alma had Stage II invasive lobular carcinoma treated with lumpectomy, chemotherapy, radiation, and planned 10 years of tamoxifen, then found a local recurrence 4.5 years after diagnosis.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Wang, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Invasive Ductal Carcinoma: Wang's Patient Story

Patient Info: Wang Youhua, Female, 60s

Right breast invasive ductal carcinoma was described as well controlled after treatment, with normal whole-body PET-CT and imaging at follow-up; exact treatment regimen and formal remission status are not reported.

Modern Cancer Hospital Guangzhou (Breast)
OutcomeResponding Well
Robbie, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Robbie's Patient Story

Patient Info: Robbie, Female | Stage IV

Biomarkers: Estrogen receptor-positive / ER-positive

Metastatic Site: Bone; liver

Living with metastatic breast cancer involving bone and liver after earlier DCIS and Stage II ER-positive breast cancer; ongoing treatment at Mass General focused on stabilization and long-term disease management.

Massachusetts General Hospital
OutcomeLiving With Cancer
Dianne, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Dianne's Survivor Story

Patient Info: Dianne Austin, Female, 40s | Stage I

Disease-free after treatment for early Stage I breast cancer, with chemotherapy and radiation completed and ongoing survivorship focused on resilience, hair loss recovery, and advocacy for better wig access for women of color.

Massachusetts General Hospital
OutcomeCancer-Free / NED
Kevin, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Cancer Council Australia
OutcomeCare Ongoing
Patty, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I Invasive Lobular Carcinoma: Patty's Patient Story

Patient Info: Patty Schone, Female, 60s | Stage I

Biomarkers: Hormone therapy used to lower estrogen; receptor results not otherwise reported

Recovering and continuing daily hormone therapy after double mastectomy, reconstruction, and 16 right-chest radiation treatments for left-breast DCIS and right-breast Stage IB invasive lobular carcinoma with lymph-node involvement.

American Cancer Society
OutcomeCare Ongoing
Karen, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Karen's Survivor Story

Patient Info: Karen Powell, Female, Under 40 | Stage I

Breast cancer survivor after diagnosis with Stage I invasive ductal carcinoma and bilateral mastectomy/reconstruction planning; source emphasizes early detection, advocacy, and survivorship rather than formal NED wording.

breastcancer.org
OutcomeSurvivorship / Surveillance
Cher, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.org
OutcomeCancer-Free / NED
Roger, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Roger's Patient Story

Patient Info: Roger, Male

Managing male breast cancer care on a lower dose of tamoxifen after severe side effects, while using support services and advocating for male breast cancer awareness.

Macmillan Cancer Support
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

How Learning To Ask For Help Can Make Life With MBC Easier

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: Not explicitly reported; HER2-targeted treatment with Herceptin and Tykerb reported

Metastatic Site: Brain; liver

Living with Stage IV metastatic breast cancer involving brain and liver; latest scans showed no evidence of disease, and she reported spending most of her Stage IV life in NED status.

breastcancer.org
OutcomeCancer-Free / NED
Genevieve, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Genevieve's Survivor Story

Patient Info: Genevieve, Female, 40s

Biomarkers: 1987 tumor not hormone-receptive; 2017 tumor hormone-receptive. 2022 full marker panel not stated.

After breast cancer episodes beginning in 1987, another tumor in 2017, and cancer found again in 2022, PET scans every 3-4 months were clear and she described herself as in remission again as of May 2025.

breastcancer.org
OutcomeCancer-Free / NED
Roxanne, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.org
OutcomeCancer-Free / NED
Vanessa, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Vanessa's Survivor Story

Patient Info: Vanessa Cuccurullo, Female | Stage I

Clear post-surgery mammogram/check-up after Stage I breast cancer treatment, healed reconstruction and reduction, and return to annual monitoring.

breastcancer.org
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Breast CancerBreast Cancer

Faith And Humility: Stage I Breast Cancer treatment and follow-up story

Patient Info: Anonymized, Female | Stage I

Completed surgery, chemotherapy, and radiotherapy for early breast cancer about 9 months before the story and was living in recovery; no explicit NED/cancer-free status is stated.

breastcancer.org
OutcomeSurvivorship / Surveillance
Michele, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Michele's Survivor Story

Patient Info: Michele Adams, Female

Breast cancer survivor after bilateral mastectomy and reconstruction; the source focuses on recovery, reconstruction, and a career change rather than formal disease status.

breastcancer.org
OutcomeSurvivorship / Surveillance
Valerie, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Valerie's Survivor Story

Patient Info: Valerie Hamilton, Female, 50s | Stage Metastatic/Advanced

Biomarkers: Triple-negative breast cancer; ER-negative; PR-negative; HER2-negative

Valerie completed chemotherapy, lumpectomy and radiation for locally advanced triple-negative breast cancer and preserved her breast/body image; no explicit NED or cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Rachel, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II BRCA2 Breast Cancer: Rachel's Patient Story

Patient Info: Rachel Zitofsky, Female, Under 40 | Stage II

Biomarkers: BRCA2 mutation

Rachel was doing well 4.5 years after Stage II breast cancer diagnosis and continued tamoxifen; her BRCA2 result also led her sister to expanded testing and preventive care.

Memorial Sloan Kettering
OutcomeCare Ongoing
Jill, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Jill's Survivor Story

Patient Info: Jill, Female | Stage I

Biomarkers: Gene profile used to help avoid chemotherapy; specific biomarkers not reported

Jill completed lumpectomy, sentinel node biopsy and 4 weeks of hypofractionated radiation for Stage I invasive ductal carcinoma, avoided chemotherapy, and moved into recovery; no explicit NED/cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Susan, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 60s

Susan had been deemed cancer-free for 10 years after breast cancer treatment, while continuing to manage chronic lymphedema through MSK support services.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Eutha, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance